Diverting water to a hydroelectric dam might seem eco-friendly, but the devastating consequences to local ecosystems cannot be ignored. Jair Bolsonaro’s government has put forward laws that ...

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.

But incredibly, thanks to ancient Roman engineering which helped to direct the overflowing waters of the dam, the deluge was diverted down a hillside and away from the town of Almonacid de la Cuba.

Além do resgate de novelas clássicas, a plataforma estreia documentários imperdíveis, como o cantor Belo, o novo talk show de Angélica, filme nacional exclusivo, e a terceira temporada da ...

O Monte Fuji ainda está sem neve, tornando este o momento mais tardio do ano em que a montanha permaneceu sem neve desde que os registros começaram há 130 anos. Os picos da montanha mais alta ...

Um desses escritores é Alexandre Dumas, e basta mencionarmos duas das suas obras mais conhecidas, mais lidas e intemporais, Os Três Mosqueteiros e O Conde de Monte Cristo. Ambas foram já levadas ao ...

The Department of Water and Sanitation’s latest weekly report revealed a significant decline in the country’s dam water capacity levels. 31 dams nationally recorded levels of under 50% of ...

After years of controversy and construction, British Columbia’s Site C dam has begun generating power. BC Hydro said Monday that the first of six generating units at the hydroelectric dam on the ...

Oct 28 (Reuters) - Swiss pharmaceutical giant Novartis (NOVN.S), opens new tab will pay Monte Rosa Therapeutics (GLUE.O), opens new tab $150 million upfront payment for a global license to develop ...

BOSTON, Oct. 28, 2024 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics, Inc. (Nasdaq: GLUE), a clinical-stage biotechnology company developing novel molecular glue degrader (MGD)-based medicines ...

Don’t stop Monte Rosa Therapeutics now. The Boston-based biotech is having a ball after signing a deal with Novartis to the tune of $150 million for a molecular glue degrader, developed using ...

Monte Rosa Therapeutics Inc (NASDAQ:GLUE) stock is trading higher on Monday after the company announced a global exclusive development and commercialization license agreement with Novartis AG ...